United States · FDA National Drug Code directory
Docusate Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55289-493_54129d13-ffb2-2e6d-e063-6394a90a6290
- Product NDC
- 55289-493
- Form
- CAPSULE
- Composition / generic term
- Docusate Sodium
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20160301
- Source listing expiry
- 20271231
Source-listed ingredients
- DOCUSATE SODIUM — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE, PLASTIC (55289-493-01) · 55289-493-01
- 12 CAPSULE in 1 BOTTLE, PLASTIC (55289-493-12) · 55289-493-12
- 14 CAPSULE in 1 BOTTLE, PLASTIC (55289-493-14) · 55289-493-14
- 30 CAPSULE in 1 BOTTLE, PLASTIC (55289-493-30) · 55289-493-30
- 60 CAPSULE in 1 BOTTLE, PLASTIC (55289-493-60) · 55289-493-60
- 90 CAPSULE in 1 BOTTLE, PLASTIC (55289-493-90) · 55289-493-90
- 180 CAPSULE in 1 BOTTLE, PLASTIC (55289-493-93) · 55289-493-93
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →